ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...

The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.

Scientists at Nagoya University in Japan have identified the genes that allow an organism to switch between living as single ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Explore how stressors during pregnancy influence foetal brain development and the impact on future neurodevelopmental ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...

Scientists have unveiled a new way to capture ultra-sharp optical images without lenses or painstaking alignment. The ...